• About
  • Licensing
  • Podcasting
  • Contact

AudioMedica.com

  • Public Health
  • Oncology
  • Cardiovascular
  • General Medicine

Delivering Antiretroviral Therapy for HIV/AIDS in Uganda – Challenges and Future Areas of Research

  • — 9 Jun, 2006
AudioMedica News
AudioMedica News
Delivering Antiretroviral Therapy for HIV/AIDS in Uganda – Challenges and Future Areas of Research
Delivering Antiretroviral Therapy for HIV/AIDS in Uganda – Challenges and Future Areas of Research
00:00 /
RSS Feed
Share
Link
Embed
Andy Haines

Andy Haines, London School of Hygiene and Tropical Medicine

In Sub-Saharan Africa, antiretroviral therapy for HIV/AIDS is becoming more available and more affordable. However, coverage is still far from complete. Andy Haines, director of the London School of Hygiene and Tropical Medicine, recently attended a workshop in Uganda which focussed on antiretroviral delivery. He spoke to Derek Thorne about the current initiatives and the challenges that lie ahead.
[audio:https://www.audiomedica.com/podcasting/infectious/andy_haines.mp3]

You may also like...

  • Maraviroc: New Antiretroviral Drug Shows Efficacy and Safety Maraviroc: New Antiretroviral Drug Shows Efficacy and Safety 13 Mar, 2007
  • John Cleland Global Population Stability: Real Hope This Century Through Family Planning 14 Aug, 2010
  • Peter Colenso Economic Downturn No Bar To Success Against AIDS 11 Jan, 2011
  • Audio Journal of Global Health Issues: Tipranavir Brings Hope for HIV-1 Patients Resistant to Standard Antiretorviral Therapy Audio Journal of Global Health Issues: Tipranavir Brings Hope for HIV-1 Patients Resistant to Standard Antiretorviral Therapy 29 Sep, 2006
  • Previous story Audio Journal of Oncology – June 7th 2006, from the ASCO Annual Meeting in Atlanta, June 2-6
  • Next story ASCO Audio Journal of Oncology – June 15th 2006
  • News

    • Mandeep Mehra MDCOVID-19 Co-Morbidity Risks Quantified from Three Continents SurveyMay 28, 2020
    • Ultrahypofractionated Radiation Just As Effective for Prostate CancerUltrahypofractionated Radiation Just As Effective for Prostate CancerMay 16, 2018
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.First evidence that genome editing made patients with AIDS more resistant to HIVMarch 8, 2014
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.Anticoagulation with warfarin can be beneficial in patients with atrial fibrillation and chronic kidney disease.March 7, 2014
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.Prostate cancer: Adult exposure to bisphenol-A linked to prostate cancer riskMarch 6, 2014
  • Related interviews

    • Microbiome Diversity Key To Survival After Allogeneic…
    • Ibrutinib: New Frontline Standard for Chronic Lymphocytic…
    • Genomic-led AML Clinical Decision Making Within Seven Days
    • Which Tasks Most Influence Pediatric PT Productivity,…
    • CT Screening Cuts Lung Cancer Deaths 24 Per Cent—Second…
  • Home
  • Public Health
  • London School of Hygiene & Tropical Medicine
  • Delivering Antiretroviral Therapy for HIV/AIDS in Uganda – Challenges and Future Areas of Research

© Copyright 2022 AudioMedica.com. Typegrid Theme by WPBandit.